Pharmacovigilance & Regulatory Affairs Consulting in China

PV Solutions Limited provides consulting services to International pharmaceutical companies on pharmacovigilance and regulatory affairs in China.

What We Offer

Services for pharmaceutical companies operating in or entering the Chinese market smoothly.

China GVP Inspection & Audit Support

Comprehensive preparation and support for pharmacovigilance inspections and audits in China. We provide documentation review, compliance assessment, inspection readiness preparation, and remote or on-site audits of your local partners.

GCP Mock Inspection/Audit

Mock GCP inspections and audits tailored for overseas sponsors' investigational sites and contract research organizations (CROs) in China. We conduct realistic audit scenarios to identify gaps and ensure readiness for regulatory inspections.

PV Strategy & Operations

Comprehensive pharmacovigilance strategy and operational frameworks including annual report, QPPV/RPPV designation, PSUR/PBRER, system files and post-market surveillance strategies.

Regulatory Affairs Consulting

Expert guidance on navigating China's GVP requirements, regulatory submissions, and compliance with NMPA standards. We provide comprehensive support for regulatory intelligence, gap analysis, and product registration.

Expertise in China's Regulatory & Pharmacovigilance Framework

PV Solutions Limited brings specialized expertise in China's complex pharmacovigilance and regulatory environment including GCP&GVP requirements, GCP inspection, GVP audit, NMPA compliance, data gap assessment. We ensure comprehensive compliance with Chinese regulatory standards and pharmacovigilance requirements throughout your product lifecycle.

GCP/GVP Audit

Comprehensive audit and assessment services for Good Clinical Practice and Good Vigilance Practice compliance, ensuring alignment with international standards and Chinese regulatory expectations

Regulatory Authority Coordination

Expert liaison with NMPA and provincial authorities for PV inspections, audits, and regulatory compliance management

China Pharmacovigilance Systems

Design and implementation of PV systems including PSMF, QMS and ICSR reporting compliant with Chinese regulatory requirements

China Market & Regulatory Strategy

Strategic guidance on market entry, product lifecycle management, and long-term regulatory strategy in China's evolving pharmaceutical landscape

Authority Inspection & Compliance Framework

Understanding China's NMPA Pharmacovigilance Inspection Structure (Guideline for Drug Pharmacovigilance Inspection - NMPA No. 2022/17)

Regulatory Authorities

National Level (NMPA)

National Medical Products Administration - Sets inspection standards and assigns inspectors to Drug Inspection Institutions

Provincial Level

Provincial Medical Products Administration oversees regional compliance and coordinates with municipalities

Municipal & County Level

Local authorities manage grassroots compliance and apply inspection standards from higher authorities

Inspection Institutions

Drug Inspection Institutions

Designated institutes conducting field inspections and building inspector information platforms

Institutes for Drug Control

Provides expertise in pharmacovigilance standards and safety monitoring protocols

Drug Evaluation & ADR Monitoring

Institutes for Drug Evaluation, Reevaluation, and Adverse Drug Reaction monitoring

PV Audit Coverage Areas

PV System & PSMF

Pharmacovigilance System Master File compliance and documentation

ICSR Management

Individual Case Safety Report collection, evaluation, and reporting procedures

Safety Monitoring

Ongoing safety surveillance and periodic safety updates (PSUR)

Inspecting Personnel

Qualified inspectors and inspection team designation and conduct

Regulatory Compliance

Alignment with GVP and GCP standards in China's regulatory environment

Unlawful Case Handling

Procedures for managing non-compliant cases and regulatory affairs coordination

About PV Solutions Limited

PV Solutions Limited help global pharmaceutical companies navigate China's complex regulatory landscape with confidence. Backed by our local experts with decades of combined experience in pharmacovigilance and regulatory affairs, we provide tailored consulting services that enable pharma companies to enter and succeed in the Chinese market.

Our team brings deep expertise in GCP and GVP audit and mock inspections, regulatory intelligence and local compliance coordination. We are committed to supporting our clients' success in the Chinese market through tailored, professional quality consulting services.

Deep expertise in NMPA regulations and Chinese pharmaceutical law
Bilingual team bridging Western pharma standards with local requirements
Serving multinational pharmaceutical companies over 25 countries

Contact

We'd love to hear from you. Whether you're planning market entry in China, conducting a mock GCP inspection/GVP audit, or need regulatory guidance, reach out to PV Solutions Limited to discuss your project.